Literature DB >> 25083454

Locoregional recurrence after neoadjuvant chemotherapy.

Masakazu Yashiro1, Naoki Aomatsu1, Tsutomu Takashima1.   

Abstract

Year:  2013        PMID： 25083454      PMCID： PMC4115718          DOI： 10.3978/j.issn.2227-684X.2012.12.01

Source DB:  PubMed          Journal:  Gland Surg        ISSN： 2227-684X


× No keyword cloud information.
  10 in total

1.  Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

Authors:  Davide Mauri; Nicholas Pavlidis; John P A Ioannidis
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

2.  Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

Authors:  Y Xing; M Foy; D D Cox; H M Kuerer; K K Hunt; J N Cormier
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

3.  Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Authors:  Harry D Bear; Stewart Anderson; Roy E Smith; Charles E Geyer; Eleftherios P Mamounas; Bernard Fisher; Ann M Brown; Andre Robidoux; Richard Margolese; Morton S Kahlenberg; Soonmyung Paik; Atilla Soran; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-04-10       Impact factor: 44.544

Review 4.  Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

Authors:  Jiri Neuzil; Marina Stantic; Renata Zobalova; Jaromira Chladova; Xiufang Wang; Lubomir Prochazka; Lanfeng Dong; Ladislav Andera; Stephen J Ralph
Journal:  Biochem Biophys Res Commun       Date:  2007-02-06       Impact factor: 3.575

5.  Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.

Authors:  Jeannie Shen; Michael Z Gilcrease; Gildy V Babiera; Merrick I Ross; Funda Meric-Bernstam; Barry W Feig; Henry M Kuerer; Ashleigh Francis; Frederick C Ames; Kelly K Hunt
Journal:  Cancer       Date:  2007-04-01       Impact factor: 6.860

6.  Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.

Authors:  N Wolmark; J Wang; E Mamounas; J Bryant; B Fisher
Journal:  J Natl Cancer Inst Monogr       Date:  2001

7.  Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.

Authors:  Eleftherios P Mamounas; Stewart J Anderson; James J Dignam; Harry D Bear; Thomas B Julian; Charles E Geyer; Alphonse Taghian; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

Review 8.  Cancer stem cell: target for anti-cancer therapy.

Authors:  Carol Tang; Beng T Ang; Shazib Pervaiz
Journal:  FASEB J       Date:  2007-07-11       Impact factor: 5.191

9.  Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

Authors:  Priya Rastogi; Stewart J Anderson; Harry D Bear; Charles E Geyer; Morton S Kahlenberg; André Robidoux; Richard G Margolese; James L Hoehn; Victor G Vogel; Shaker R Dakhil; Deimante Tamkus; Karen M King; Eduardo R Pajon; Mary Johanna Wright; Jean Robert; Soonmyung Paik; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

10.  CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer.

Authors:  Naoki Aomatsu; Masakazu Yashiro; Shinichiro Kashiwagi; Tsutomu Takashima; Tetsuro Ishikawa; Masahiko Ohsawa; Kenichi Wakasa; Kosei Hirakawa
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.